Helius Medical Technologi... (HSDT)
NASDAQ: HSDT
· Real-Time Price · USD
1.11
-0.03 (-2.63%)
At close: Jun 06, 2025, 3:59 PM
1.07
-3.30%
After-hours: Jun 06, 2025, 05:58 PM EDT
Helius Medical Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|
| Product Revenue | 493K | 625K | 1.45M |
| Product Revenue Growth | -21.12% | -57.02% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Canada Revenue | 295K | 281K | 460K |
| Canada Revenue Growth | +4.98% | -38.91% | n/a |
| United States Revenue | 181K | 324K | 318K |
| United States Revenue Growth | -44.14% | +1.89% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.99M | 2.18M | 2.85M | 2.46M | 2.63M | 1.63M | 2.2M | 2.57M | 2.87M | 1.97M | 3.39M | 2.46M | 2.82M | 2.36M | 2.86M | 4.74M | 2.15M | 2.09M | 2.36M | 2.28M | 2.66M | 3.81M | 4.29M | 3.85M | 4.58M | 3.56M | 2.56M | 8.87M | 2.15M | 2.59M | 2.17M | 2.04M | 1.45M | 1.93M | 1.55M |
| Selling, General, and Administrative Revenue Growth | +37.47% | -23.58% | +16.00% | -6.68% | +61.34% | -25.68% | -14.52% | -10.61% | +46.11% | -42.03% | +37.87% | -12.70% | +19.55% | -17.52% | -39.73% | +120.24% | +3.11% | -11.37% | +3.20% | -14.20% | -30.06% | -11.30% | +11.60% | -16.07% | +28.57% | +39.02% | -71.12% | +311.79% | -16.92% | +19.82% | +6.00% | +40.86% | -25.01% | +24.82% | n/a |
| Research and Development Revenue | 945K | 924K | 1.08M | 870K | 788K | 650K | 722K | 684K | 886K | 794K | 751K | 953K | 1.76M | 1.81M | 1.49M | 1.38M | 1.32M | 827K | 1.33M | 1.31M | 1.12M | 1.6M | 1.51M | 2.27M | 2.68M | 2.16M | 2.31M | 2.92M | 2.55M | 3.27M | 3.8M | 1.35M | 653.88K | 981.73K | 1.29M |
| Research and Development Revenue Growth | +2.27% | -14.21% | +23.79% | +10.41% | +21.23% | -9.97% | +5.56% | -22.80% | +11.59% | +5.73% | -21.20% | -45.98% | -2.43% | +21.42% | +8.13% | +4.64% | +59.13% | -37.68% | +1.45% | +16.79% | -29.96% | +6.18% | -33.80% | -15.14% | +24.18% | -6.50% | -20.95% | +14.46% | -21.86% | -14.01% | +181.71% | +106.18% | -33.40% | -23.99% | n/a |